Literature DB >> 19335135

Age-dependent revascularization patterns in the treatment of moyamoya disease in a European patient population.

Marcus Czabanka1, Peter Vajkoczy, Peter Schmiedek, Peter Horn.   

Abstract

OBJECT: Different revascularization procedures are used in the treatment of patients with moyamoya disease (MMD). The aim of this study was to investigate the relative contribution of direct and indirect revascularization procedures to the restoration of collateral blood supply in adult and pediatric patients with MMD.
METHODS: The authors performed 39 combined cerebral revascularization procedures (standard extraintracranial bypass [STA-MCA bypass] plus encephalomyosynangiosis [EMS]) in 10 pediatric and 10 adult patients. All patients underwent physical examination and digital subtraction angiography before and 6 months after surgery. The STA-MCA bypass and EMS function were graded as Grade I (poor), II (moderate), or III (good) on the basis of the angiograms.
RESULTS: In pediatric patients, bypass function was Grade I in 12, Grade II in 8, and Grade III in 0 hemispheres; EMS function was Grade I in 0, Grade II in 12, and Grade III in 8 hemispheres. In the adult patients, bypass function was Grade I in 8, Grade II in 8, and Grade III in 3 hemispheres; EMS function was Grade I in 10 hemispheres, Grade II in 5, and Grade III in 1 hemisphere. In the pediatric patients disease was classified as improved in 14 hemispheres on the basis of clinical results and stable in 6. In the adults it was classified as improved in 12 hemispheres stable in 7 hemispheres.
CONCLUSIONS: Combined revascularization led to good angiographic and clinical results in both patient populations. Especially in pediatric patients, EMS represents a suitable alternative to bypass surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19335135     DOI: 10.3171/2009.1.FOCUS08298

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  8 in total

1.  Balanced single-vector co-delivery of VEGF/PDGF-BB improves functional collateralization in chronic cerebral ischemia.

Authors:  Aiki Marushima; Melina Nieminen; Irina Kremenetskaia; Roberto Gianni-Barrera; Johannes Woitzik; Georges von Degenfeld; Andrea Banfi; Peter Vajkoczy; Nils Hecht
Journal:  J Cereb Blood Flow Metab       Date:  2019-01-09       Impact factor: 6.200

2.  Predictive factors for acute thrombogenesis occurring immediately after bypass procedure for moyamoya disease.

Authors:  Takeshi Mikami; Hime Suzuki; Ryo Ukai; Katsuya Komatsu; Yukinori Akiyama; Masahiko Wanibuchi; Kiyohiro Houkin; Nobuhiro Mikuni
Journal:  Neurosurg Rev       Date:  2019-02-14       Impact factor: 3.042

3.  Changes in cerebral blood flow in the postoperative chronic phase after combined cerebral revascularization for moyamoya disease with ischaemic onset.

Authors:  Yoshio Araki; Takashi Mamiya; Naotoshi Fujita; Kenji Uda; Kinya Yokoyama; Fumiaki Kanamori; Kai Takayanagi; Kazuki Ishii; Masahiro Nishihori; Kazuhito Takeuch; Kuniaki Tanahashi; Yuichi Nagata; Yusuke Nishimura; Takafumi Tanei; Masaki Sumitomo; Sho Okamoto; Takashi Izumi; Katsuhiko Kato; Ryuta Saito
Journal:  Neurosurg Rev       Date:  2022-03-23       Impact factor: 3.042

4.  Angiographic Characteristics of Cerebral Perfusion and Hemodynamics of the Bridging Artery After Surgical Treatment of Unilateral Moyamoya Disease.

Authors:  Kun Zhang; Wei Ren; Yu-Xue Sun; Xin-Jun Wang; Chao-Yue Li; Zi-Liang Wang; Tian-Xiao Li; Bu-Lang Gao
Journal:  Front Neurosci       Date:  2022-06-14       Impact factor: 5.152

5.  Angiographic results of indirect and combined bypass surgery for adult moyamoya disease.

Authors:  In Jae Choi; Sung Jin Cho; Jae Chil Chang; Sukh Que Park; Hyung Ki Park
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2012-09-28

6.  Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management.

Authors:  Sherif Rashad; Miki Fujimura; Kuniyasu Niizuma; Hidenori Endo; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2016-05-16       Impact factor: 3.042

7.  2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society.

Authors:  Miki Fujimura; Teiji Tominaga; Satoshi Kuroda; Jun C Takahashi; Hidenori Endo; Kuniaki Ogasawara; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2022-02-22       Impact factor: 2.036

8.  The Efficacy of Single Barrel Superficial Temporal Artery-middle Cerebral Artery Bypass in Treatment of Adult Patients with Ischemic-type Moyamoya Disease.

Authors:  Mahnjeong Ha; Chang Hwa Choi; Jae Il Lee; Seung Heon Cha; Sang Weon Lee; Jun Kyeung Ko
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2016-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.